Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation SEATTLE, /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa ...

An emerging internet sub-community of men values physical looks over all other character traits, and goes to extreme lengths ...

The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.

Coherus Oncology formally introduces non-proprietary name: tagmokitug--Publication shows picomolar affinity for CCR8 with no off-target binding ...

The new rules introduce a fast-track notification route, enabling quicker starts for lower-risk trials and maintaining safety ...

AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

Research-use-only offerings are commercially available, enabling immediate product and service revenue generation ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Patients who are prescribed antibiotics during immune checkpoint blockade therapy for solid tumors face a heightened risk for ...

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

My list of medically related anniversaries for 2026 includes William Withering’s Botany, The Botanical Arrangement of All the Vegetables Naturally Growing in Great Britain , which was published 250 ...